Search

Stephen Kanes

from Boston, MA
Get Report
Related to:
Hannah T Lynch, 30Lisa Lynch, 62Suzanne J Lynch, 58Stephen J Lynch, 69
Connected to:
Janet L Kanes, 67Panos J Kanes, 71Steven R Kanes, 78Darcie S Kaneshiro, 30Darren M Kaneshiro, 57Evelyn S Kaneshiro, 61Karen A Kaneshiro, 72Kim D Kaneshiro, 68Miki A Kaneshiro, 28Nikki A Kaneshiro, 41

Stephen Kanes Phones & Addresses

  • Boston, MA

Work

Company: Astrazeneca Aug 2008 Position: Medical science senior director

Education

Degree: MD/PhD School / High School: Stony Brook University Health Sciences Center School of Medicine 1987 to 1999 Specialities: Medicine/Molecular and Cellular Pharmacology

Skills

Neuroscience • Neurology • Pharmacology • Clinical Development • Drug Development • Clinical Research • Clinical Trials • Pharmaceutical Industry • Medical Affairs • Psychiatry • Medicine • Drug Discovery • Life Sciences • Biotechnology • Lifesciences • Molecular Biology • Cro • Medical Education • Regulatory Submissions • Translational Medicine • Clinical Pharmacology • Protocol • Therapeutic Areas • Medical Writing • Pharmaceutics • Gcp • Fda • Biopharmaceuticals • Pharmacovigilance • Translational Research • Infectious Diseases • Biomarkers • Genetics • Regulatory Affairs • Ctms • Clinical Data Management • Edc • Diabetes • Global Drug Development • Cro Management

Industries

Biotechnology

Resumes

Resumes

Stephen Kanes Photo 1

Chief Medical Officer

View page
Location:
215 1St St, Cambridge, MA 02142
Industry:
Biotechnology
Work:
AstraZeneca since Aug 2008
Medical Science Senior Director
AstraZeneca Pharmaceuticals Feb 2008 - Aug 2008
Group Director-Neuroscience Early Development
AstraZeneca Sep 2006 - Feb 2008
Director-Clinical Research-Discovery Medicine
MedCases/IC-AXON 2003 - 2006
Consultant
University of Pennsylvania Jul 1999 - Jul 2006
Assistant Professor of Psychiatry
Education:
Stony Brook University Health Sciences Center School of Medicine 1987 - 1999
MD/PhD, Medicine/Molecular and Cellular Pharmacology University of Pennsylvania 1982 - 1986
BA, Biological Basis of Behavior, Premed
Skills:
Neuroscience
Neurology
Pharmacology
Clinical Development
Drug Development
Clinical Research
Clinical Trials
Pharmaceutical Industry
Medical Affairs
Psychiatry
Medicine
Drug Discovery
Life Sciences
Biotechnology
Lifesciences
Molecular Biology
Cro
Medical Education
Regulatory Submissions
Translational Medicine
Clinical Pharmacology
Protocol
Therapeutic Areas
Medical Writing
Pharmaceutics
Gcp
Fda
Biopharmaceuticals
Pharmacovigilance
Translational Research
Infectious Diseases
Biomarkers
Genetics
Regulatory Affairs
Ctms
Clinical Data Management
Edc
Diabetes
Global Drug Development
Cro Management

Business Records

Name / Title
Company / Classification
Phones & Addresses
Stephen Kanes
Chief Marketing Officer
SAGE Therapeutics
Biotechnology · Mfg Pharmaceutical Preparations
215 1 St, Cambridge, MA 02142
29 Newbury St, Boston, MA 02116

Publications

Us Patents

Methods Of Treating Epilepsy Or Status Epilepticus

View page
US Patent:
20140057885, Feb 27, 2014
Filed:
Aug 21, 2013
Appl. No.:
13/972851
Inventors:
Kiran Reddy - Boston MA, US
Stephen Jay Kanes - Swarthmore PA, US
Assignee:
SAGE THERAPEUTICS, INC. - Cambridge MA
International Classification:
A61K 31/573
US Classification:
514182
Abstract:
Described herein are methods of treating epilepsy or status epilepticus, e.g., convulsive status epilepticus, e.g., early status epilepticus, established status epilepticus, refractory status epilepticus, super-refractory status epilepticus, e.g., super-refractory generalized status epilepticus; non-convulsive status epilepticus, e.g., generalized status epilepticus, complex partial status epilepticus; generalized periodic epileptiform discharges; periodic lateralized epileptiform discharges; a seizure, e.g., acute repetitive seizures, cluster seizures, the method comprising administering to the subject a neuroactive steroid.
Control profile
Stephen Kanes from Boston, MA Get Report